Indication

GLUT1 deficiency syndrome

1 clinical trial

1 product

Clinical trial

An Open-label Intermediate-size Treatment Protocol for the Urgent Treatment of Seriously Ill Patients With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) With Triheptanoin (UX007)

Status:

Product